Inhibitory effect of perilla leaf extract and luteolin on mouse skin tumor promotion

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 4, 2003, Pages 560-563

  Ueda, Hiroshi ^a   Yamazaki, Chikako ^a   Yamazaki, Masatoshi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

12 O tetradecanoylphorbol 13 acetate; Chemoprevention; Luteolin; Perilla frutescens

Indexed keywords

LUTEOLIN; PERILLA LEAF EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; FLAVONOID; GROWTH INHIBITOR;

ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; FEMALE; INHIBITION KINETICS; NONHUMAN; SKIN TUMOR; STATISTICAL SIGNIFICANCE; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; MOUSE; PATHOLOGY; PERILLA FRUTESCENS; PLANT LEAF;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FLAVONOIDS; GROWTH INHIBITORS; LUTEOLIN; MICE; MICE, INBRED ICR; PERILLA FRUTESCENS; PLANT EXTRACTS; PLANT LEAVES; SKIN NEOPLASMS;

EID: 0642286439     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.560     Document Type: Article

References (21)

1. Kurita N., Koike S., Agric Biol. Chem, 46, 159-166 (1982).
2. Ueda H., Yamazaki M., Biosci. Biotechnol Biochem., 61, 1292-1295 (1997).
3. Ueda H, Yamazaki M., BIOSCI. Biotechnol. Biochem., 65, 1673-1675 (2001).
4. Imaoka K., Inoue S, Takahashi T, Kojima Y., Allergy, 42, 74-80 (1993).
5. Ishihara T., Okamoto I., Masaki N., Kohno K, Tanimoto T., Ikegami H, Kurimoto M, Allergy, 48, 443-450 (1999).
6. Shin T. Y., Kim Sa. H., Kim Su. H., Kim Y. K., Park H. J, Chae B S., Jung H. J., Kim H. M., Immunopharmacol Immunotoxicol, 22, 489-500 (2000).
7. Makino T., Ono T., Muso E, Honda G., Sasayama S., Nephron. 83, 40-46 (1999).
8. Ueda H., Yamazaki C., Yamazaki M., Biol. Pharm Bull., 25, 1197-1202 (2002).
9. Havsteen B., Biochem. Pharmacol., 32, 1141-1148 (1983).
10. Cooks N. C., Samnlan S., J. Nutr Biochem., 7, 66-76 (1996).
11. Middleton E., Kandaswami C, Biochem. Pharmacol., 43, 1167-1179 (1992).
12. Gryglewski R J., Korbut R., Robak J., Swies J, Biochem. Pharmacol., 36, 317-322 (1987).
13. de Whalley C. V., Rankin S. M., Hoult J. R., Jessup W., Leake D. S., Biochem. Pharmacol, 39, 1743-1750 (1990).
14. Yoshida M., Sakai T., Hosokawa N, Marui N., Matsumoto K, Fujioka A., Nishino H, Aoike A., FEBS Lett., 260, 10-13 (1990).
15. Katan M. B., Arch. Toxicol Suppl, 20, 237-248 (1998).
16. Kim H. K., Cheon B. S., Kim Y. H., Kim S. Y., Kim H. P., Biochem. Pharmacol., 58, 759-765 (1999).
17. Nagao A, Seki M., Kobayashi H., Biosci Biotechnol. Biochem., 63, 1787-1790 (1999).
18. Shimoi K., Saka N., Kaji K., Nozawa R, Kinae N, Biofaaors. 12, 181-186 (2000).
19. Bormann H., Melzig M. F., Pharmazie, 55, 129-132 (2000).
20. Boutwell R. K, CRC Crit Rev. Toxicol, 2, 1197-1201 (1974).
21. Suganuma M., Okabe S, Marino M. W, Sakai A., Sueoka E. Fujiki H., Cancer Res., 59, 4516-4518 (1999).